Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001091818-25-000053
Filing Date
2025-05-13
Accepted
2025-05-13 08:11:44
Documents
37
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 QTR. REPORT - MARCH 31, 2025 bfnh20250331_10q.htm   iXBRL 10-Q 229397
2 CERTIFICATION ex311.htm EX-31.1 4737
3 CERTIFICATOIN ex312.htm EX-31.2 4930
4 CERTIFICATOIN ex321.htm EX-32.1 2002
5 CERTIFICATION ex322.htm EX-32.2 1933
11 bfnhlogo2019001.jpg GRAPHIC 21193
  Complete submission text file 0001091818-25-000053.txt   1510824

Data Files

Seq Description Document Type Size
6 bfnh-20250331.xsd EX-101.SCH 13370
7 bfnh-20250331_cal.xml EX-101.CAL 20413
8 bfnh-20250331_def.xml EX-101.DEF 28385
9 bfnh-20250331_lab.xml EX-101.LAB 114563
10 bfnh-20250331_pre.xml EX-101.PRE 85405
39 EXTRACTED XBRL INSTANCE DOCUMENT bfnh20250331_10q_htm.xml XML 84116
Mailing Address 2020 GENERAL BOOTH BLVD SUITE 230 VIRGINIA BEACH VA 23454
Business Address 2020 GENERAL BOOTH BLVD SUITE 230 VIRGINIA BEACH VA 23454 757-306-6090
BIOFORCE NANOSCIENCES HOLDINGS, INC. (Filer) CIK: 0001310488 (see all company filings)

EIN.: 852138858 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51074 | Film No.: 25937271
SIC: 3826 Laboratory Analytical Instruments
(CF Office: 08 Industrial Applications and Services)